Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJC19P8 is a **pseudogene** from the DnaJ heat shock protein family, meaning it is a genomic DNA segment resembling a gene but is generally regarded as non-functional due to accumulated mutations or lack of regulatory elements necessary for transcription or translation[1][5]. It does not produce any functional protein and is not known to be involved in any physiological pathway, disease, or therapeutic mechanism. Pseudogenes like DNAJC19P8 may sometimes be transcribed or play subtle regulatory roles, but there is no direct evidence for this gene being clinically relevant as a therapeutic target. It is not a receptor, enzyme, transporter, or conventional drug target[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member C19 pseudogene 8 (DNAJC19P8).